Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Cataracts in adults: management

NICE guideline
Reference number: NG77
Published: 26 October 2017

Register as a stakeholder

History

Guidance published

Committee member list (PDF 298 KB)

Published:

26 October 2017
Equality impact assessment (PDF 295 KB)

Published:

26 October 2017
Consultation comments and responses (PDF 4.23 MB)

Published:

26 October 2017

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 3.62 MB)

Published:

12 May 2017
Guideline appendix A (PDF 296 KB)

Published:

12 May 2017
Guideline appendix B (PDF 262 KB)

Published:

12 May 2017
Guideline appendix C (PDF 1010 KB)

Published:

12 May 2017
Guideline appendix D (PDF 764 KB)

Published:

12 May 2017
Guideline appendix E (PDF 12.43 MB)

Published:

12 May 2017
Guideline appendix F (PDF 1.97 MB)

Published:

12 May 2017
Guideline appendix G (PDF 3.46 MB)

Published:

12 May 2017
Guideline appendix H (PDF 5.91 MB)

Published:

12 May 2017
Guideline appendix I (PDF 198 KB)

Published:

12 May 2017
Guideline appendix J (PDF 2.67 MB)

Published:

12 May 2017
Guideline appendix K (PDF 360 KB)

Published:

12 May 2017
Guideline appendix L (PDF 456 KB)

Published:

12 May 2017
Equality impact assessment 3 (PDF 304 KB)

Published:

12 May 2017
Comments form LARGE FONT (MSWord 62 KB)

Published:

12 May 2017
Comments form (MSWord 62 KB)

Published:

12 May 2017
Stakeholder list (PDF 40 KB)

Published:

12 May 2017
Short version of draft guideline (PDF 413 KB)

Published:

12 May 2017
Short version of draft guideline LARGE FONT (PDF 417 KB)

Published:

12 May 2017

Stakeholder list updated

Stakeholder list (PDF 43 KB)

Published:

27 June 2017

Pre-consultation documents released

Search strategies (PDF 761 KB)

Published:

24 May 2017
Economic plan (PDF 146 KB)

Published:

24 May 2017
Review questions (PDF 174 KB)

Published:

24 May 2017

Committee meetings

Committee meeting
Minutes 1 (PDF 273 KB)

Published:

25 May 2017
Minutes 2 (PDF 318 KB)

Published:

25 May 2017
Minutes 3 (PDF 254 KB)

Published:

25 May 2017
Minutes 4 (PDF 253 KB)

Published:

25 May 2017
Minutes 5 (PDF 259 KB)

Published:

25 May 2017
Minutes 6 (PDF 374 KB)

Published:

25 May 2017
Minutes 7 (PDF 318 KB)

Published:

25 May 2017
Minutes 8 (PDF 294 KB)

Published:

25 May 2017
Minutes 9 (PDF 312 KB)

Published:

25 May 2017
Minutes 10 (PDF 318 KB)

Published:

25 May 2017
Minutes 11 (PDF 321 KB)

Published:

25 May 2017
Minutes 12 (PDF 320 KB)

Published:

25 May 2017
Minutes 13 (PDF 313 KB)

Published:

18 October 2017
Minutes 14 (PDF 309 KB)

Published:

18 October 2017

Committee list updated

Committee member list (PDF 296 KB)

Published:

25 May 2017

Scope published

Final scope (PDF 212 KB)

Published:

12 August 2016

Consultation comments published

Consultation comments and responses (MSWord 191 KB)

Published:

13 November 2015

Equality impact assessment uploaded

Equality impact assessment (MSWord 28 KB)

Published:

13 November 2015

Cataracts: scope consultation

Cataracts: scope consultation information
Cataracts: draft scope (PDF 192 KB)

Published:

24 February 2015

Cataracts: list of registered stakeholders

Cataracts: list of registered stakeholders (PDF 19 KB)

Published:

08 June 2015